Ruesch Center
banner
rueschcenter.bsky.social
Ruesch Center
@rueschcenter.bsky.social
Lombardi Comprehensive Cancer Center's GI clinicians and researchers working together to combine expertise in molecular medicine, novel therapeutics, translational research, and a patient-centered philosophy to improve outcomes for GI Cancer patients
Read Abraham’s full essay on her diagnosis and journey with colon cancer with interviews from other survivors, advocates, and clinicians, including Dr. John Marshall.
New York Magazine
Colorectal cancer is the second-most-common cause of cancer fatalities in the United States, with 150,000 diagnoses annually and 52,000 deaths; only lung cancer kills more. It has grabbed headlines...
www.facebook.com
August 28, 2025 at 2:57 AM
Liquid, Tissue, or Both? Expediting Next-Generation Sequencing Results to Guide Treatment Selection in Patients With Metastatic Colorectal Cancer dailynews.ascopubs.org/do/liquid-ti...
Liquid, Tissue, or Both? Expediting Next-Generation Sequencing Results to Guide Treatment Selection in Patients With Metastatic Colorectal Cancer
Knowledge of biomarkers is critical to guide first-line treatment selection in patients with metastatic colorectal cancer. Liquid biopsies and tissue-based sequencing tests have different advantages, ...
dailynews.ascopubs.org
August 28, 2025 at 2:51 AM
Fit, Young, and at Risk for Precancerous Colon Lesions? www.medpagetoday.com/gastroentero...
Fit, Young, and at Risk for Precancerous Colon Lesions?
Study finds that extreme runners may have a higher risk of colon cancer, but it's not clear why
www.medpagetoday.com
August 26, 2025 at 3:25 PM
Join us tomorrow morning, Friday, June 27th, from 9:00- 10:30 am, to review research from the #ASCO25 Annual Meeting. We will highlight the most compelling abstracts in Colorectal, Pancreatic, Liver, and Upper GI cancers via Zoom. Register now: bit.ly/4k63Swd to receive the link.
June 26, 2025 at 11:12 PM
June 12, 2025 at 8:40 PM
The Hidden Barriers Holding Back Cancer's Most Promising Treatments: Samir N. Khleif, MD of @georgetownlombardi.bsky.social shares his thoughts on the pace of innovation in immune checkpoint inhibitors.

time.com/7292783/canc...
The Hidden Barriers Holding Back Promising Cancer Treatments
A perfect storm of scientific, economic, and cultural barriers are holding back immunotherapy's true potential, writes Samir Khleif.
time.com
June 11, 2025 at 10:05 PM
We are excited to celebrate our 10th Annual GI Cancer Patient Summit with Hope Connections for Cancer Support and @georgetownlombardi.bsky.social on Saturday, July 12, 2025, from 10:00 am- 1:00 pm EST. The summit provides information and tools to manage cancer care. Learn more: bit.ly/GISummit25
GI Cancer Patient Summit: Saturday, July 12, 2025. - The Ruesch Center for the Cure of Gastrointestinal Cancers
We are looking forward to the 10th Annual GI Cancer Patient Summit. The Summit is a partnership between The Ruesch Center and Hope Connections for Cancer Support. This year’s topics are still in devel...
bit.ly
June 11, 2025 at 10:03 PM
EGFR Inhibitors in the Treatment of Stage IV CRC:
Benjamin Weinberg, MD, discusses with @medscape.com Hematology and Oncology Decision Point.

decisionpoint.medscape.com/oncology/vie...
EGFR Inhibitors in the Treatment of Stage IV CRC
Benjamin A. Weinberg, MD discusses EGFR inhibitors in the treatment of stage IV CRC.
decisionpoint.medscape.com
June 11, 2025 at 10:02 PM
Join @medstarhealth.bsky.social for the 2025 Esophageal Symposium. Attendees will gain insights into identifying the pathophysiology associated with esophageal conditions, as well as guidance on testing, indications for therapy, and available endoscopic and surgical treatments. bit.ly/3FHX6On
June 5, 2025 at 11:42 PM
After #ASCO25, stay up-to-date on the latest GI Cancer Research. View this week's tailored GI Cancer publication output via bit.ly/454GquF and sign up to have this weekly list delivered to your inbox: bit.ly/RueschWeeklyPub.
June 2, 2025 at 11:33 PM
Join us to review exciting research from the #ASCO25 Annual Meeting. Drs. Marshall, Weinberg, Noel, and Mukherji will highlight the most compelling abstracts in Colorectal, Pancreatic, Liver, and Upper GI cancers on June 27th via Zoom. Register today: bit.ly/4k63Swd @georgetownlombardi.bsky.social.
June 2, 2025 at 11:30 PM
John L. Marshall, MD, (@marshalj23.bsky.social) discusses unmet needs in the targeted therapy space and the importance of optimizing dosing in colorectal cancer with @targetedonc.bsky.social. www.targetedonc.com/view/unmet-n...
Unmet Needs and Therapy Modifications Relevant in the CRC Landscape
John L. Marshall, MD, discusses unmet needs in the targeted therapy space and the importance of optimizing dosing in colorectal cancer.
www.targetedonc.com
May 22, 2025 at 4:55 PM
Today, on Clinical Trials Day, we recognize and celebrate the contributions of clinical research professionals in advancing research at Lombardi Comprehensive Cancer Center. The Lombardi Clinical Trials Office provides administrative, nursing, and data management support for clinical trials.
May 20, 2025 at 9:53 PM
Register today for the 10th Annual GI Cancer Patient Summit on Saturday, July 12, 2025, from 10:00 am- 1:00 pm EST. The summit provides information and tools to manage cancer care. This free event is a partnership with Hope Connections for Cancer Support. bit.ly/GISummit25
May 19, 2025 at 8:10 PM
Learn more about BellRinger today! Join Team Ruesch as a rider, volunteer, or supporter as we gear up for BellRinger on October 24-25, 2025. 100% of funds raised from BellRinger support cancer research at @georgetownlombardi.bsky.social. bit.ly/RueschBellRinger
BellRinger | Team Ruesch
Support me as I fundraise for cancer research at Georgetown Lombardi Comprehensive Cancer Center
bit.ly
May 16, 2025 at 10:08 PM
This week, we highlighted research by Emil Lou (@cancerassassin1.bsky.social), Modassir S Choudhry, Timothy K Starr, Timothy D Folsom, Jason Bell, Blaine Rathmann, Anthony P DeFeo, Jihyun Kim, Branden S Moriarity, and others published in @thelancetoncol.bsky.social. Learn more: bit.ly/3Fkx2bI.
May 15, 2025 at 11:17 PM
In this week's Ruesch Center GI Cancers publication search, @marshalj23.bsky.social highlighted research by Julien Taieb, Pierre Laurent-Puig, and others published in the Journal of Clinical Oncology. bit.ly/3Fkx2bI. Learn more: youtu.be/JlqL1f6vyak?...
Combined Analyses of Circulating Tumor DNA and Immunoscore in Patients With Stage III Colon Cancer.
YouTube video by The Ruesch Center
youtu.be
May 15, 2025 at 10:46 PM
On Thursday, May 15th, join thousands of commuters in the DMV for Bike to Work Day! BellRinger will host its own stop at Georgetown Waterfront Park. Stop by to learn how to gear up to support critical research at @georgetownlombardi.bsky.social . Register today: bit.ly/4k5BABC.
May 9, 2025 at 5:23 PM
View this week's tailored GI Cancer publication output via bit.ly/431rg6J. Sign up today to have this weekly list delivered to your inbox: bit.ly/RueschWeeklyPub. What research excited you this week?
May 8, 2025 at 10:03 PM
Join Smith Center for the Healing and the Arts, Hope Connections for Cancer Support Community, Washington, D.C., and Cancer Choices for this virtual event on Wednesday, May 21st. Learn more and register today: smithcenter.org/programs-ret...
May 5, 2025 at 11:52 PM
This week, we highlighted research by Jill P Smith, Narayan Shivapurkar, Wenqiang Chen, Godhanjali Chekuri, Amani Dabney, Kyle Holmes, Hong Cao, Ruvanthi N Kularatne, and Stephan T Stern published in the Journal of Molecular Cancer Therapeutics. Learn more: bit.ly/4lTknwY
April 30, 2025 at 10:26 PM
Save the Date for the 16th Annual Ruesch Center Symposium- Nov 21-22, 2025! @georgetownlombardi.bsky.social @marshalj23.bsky.social @onclive.bsky.social @medstarhealth.bsky.social
April 30, 2025 at 5:48 PM
Pancreatic Cancer 2025: After More Than 30 Years, Is That Light on the Horizon? @marshalj23.bsky.social shares insights in the Spring Issue of Oncolytics Today. Read the full article, pages 77-79-https://www.ncoda.org/news/oncolytics-today-spring-2025/
April 23, 2025 at 5:59 PM
In an interview with Peers & Perspectives in Oncology, Dr. John Marshall discussed treatment approaches and sequencing for refractory colorectal cancer.
www.targetedonc.com/view/managin...
Managing Colorectal Cancer Requires Using All Available Options
In an interview with Peers & Perspectives in Oncology, John L. Marshall, MD, discussed treatment approaches and sequencing for refractory colorectal cancer.
www.targetedonc.com
April 23, 2025 at 5:22 PM
This week, we highlighted exciting research by Berend J van der Wilk, Ben M Eyck, Bas P L Wijnhoven, Sjoerd M Lagarde, J Jan B van Lanschot, and others published in @thelancetoncol.bsky.social. Learn more: bit.ly/3GkX52V.
April 22, 2025 at 11:40 PM